semaglutide cardiovascular risk Effects of on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6 Oral Semaglutide and Cardiovascular Outcomes
Description
Diabetology & Metabolic Syndrome , 16 (1)
This peptide-pathway test maps your genetic predisposition across 14 weight-regulating pathways, including GLP-1R sensitivity (rs6923761), GIPR response (rs1800437), and FTO metabolic variants (rs9939609), allowing your provider to personalize your compound and dosing strategy
The bottom line Trulicity and Ozempic are both injectable GLP-1 RA that are FDA-approved for treating Type 2 diabetes
Article Summary GLP-1 medications like semaglutide have transformed obesity and diabetes treatment, helping millions lose weight and improve metabolic health
